[Role of vasoactive agents in the management of stage II obliterative arteriopathies of the legs. Report of the AMIS-2 group].
D000367:Age Factors; D000465:Algorithms; D001162:Arteriosclerosis Obliterans / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007866:Leg; D012307:Risk Factors; D012720:Severity of Illness Index; D014665:Vasodilator Agents / Q000627:therapeutic use
D014665:Vasodilator Agents